Abiopharma

Ainos Articulates Its Platform Strategy to Digitize Smell as the Next Native AI Data Language

Align Technology to Announce Fourth Quarter and 2025 Results on February 4, 2026

CDT Engages NJS Foresight Bio-Advisory to Support Solid-Form Out-Licensing Strategy

Hoth Therapeutics Expands Oncology Pipeline with Dual Patent Filings Establishing Novel Oncology Dermatology IP Platform

Johnson & Johnson - Johnson & Johnson Announces Quarterly Dividend for First Quarter 2026

Johnson & Johnson Announces Quarterly Dividend for First Quarter 2026

Boston Scientific announces participation in the J.P. Morgan Healthcare Conference and conference call discussing fourth quarter and full year 2025 results

Lantheus Announces Closing of SPECT Business Sale to SHINE Technologies

Genelux Corporation Announces Appointment of Jason Litten, M.D., as Chief Medical Officer

BridgeBio to Host Achondroplasia Investor Webinar on Friday, January 9th at 8:00 am ET